Rong Zhou is SENIOR EVP, PRODUCTION CENTER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 118,469 shares of AMPH, which is worth approximately $4.32 Million. The most recent transaction as insider was on Dec 13, 2024, when has been sold 8,000 shares (Common Stock) at a price of $45.23 per share, resulting in proceeds of $361,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0.07% 3M change
5.38% 12M change
Total Value Held $4.32 Million

Rong Zhou Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
SELL
Open market or private sale
$361,840 $45.23 p/Share
8,000 Reduced 6.33%
118,469 Common Stock
Dec 13 2024
BUY
Exercise of conversion of derivative security
$90,640 $11.33 p/Share
8,000 Added 5.95%
126,469 Common Stock
Dec 12 2024
SELL
Open market or private sale
$310,940 $44.42 p/Share
7,000 Reduced 5.58%
118,469 Common Stock
Dec 12 2024
BUY
Exercise of conversion of derivative security
$79,310 $11.33 p/Share
7,000 Added 5.28%
125,469 Common Stock
Nov 12 2024
SELL
Open market or private sale
$336,929 $48.88 p/Share
6,893 Reduced 5.5%
118,388 Common Stock
Nov 12 2024
BUY
Exercise of conversion of derivative security
$103,050 $14.95 p/Share
6,893 Added 5.22%
125,281 Common Stock
Sep 13 2024
SELL
Open market or private sale
$144,780 $48.26 p/Share
3,000 Reduced 2.47%
118,388 Common Srock
Sep 13 2024
BUY
Exercise of conversion of derivative security
$44,850 $14.95 p/Share
3,000 Added 2.41%
121,388 Common Srock
Aug 26 2024
SELL
Open market or private sale
$193,400 $48.35 p/Share
4,000 Reduced 3.27%
118,388 Common Srock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$59,800 $14.95 p/Share
4,000 Added 3.16%
122,388 Common Srock
Mar 17 2024
SELL
Payment of exercise price or tax liability
$84,421 $43.05 p/Share
1,961 Reduced 1.63%
118,016 Common Stock
Mar 16 2024
SELL
Payment of exercise price or tax liability
$101,382 $43.05 p/Share
2,355 Reduced 1.93%
119,977 Common Srock
Mar 15 2024
SELL
Payment of exercise price or tax liability
$52,477 $43.05 p/Share
1,219 Reduced 0.99%
122,332 Common Srock
Mar 06 2024
SELL
Payment of exercise price or tax liability
$64,370 $46.31 p/Share
1,390 Reduced 1.11%
123,551 Common Srock
Mar 04 2024
BUY
Grant, award, or other acquisition
-
12,521 Added 9.11%
124,941 Common Srock
Dec 04 2023
SELL
Open market or private sale
$209,364 $59.58 p/Share
3,514 Reduced 3.03%
112,420 Common Stock
Dec 04 2023
BUY
Exercise of conversion of derivative security
$56,891 $16.19 p/Share
3,514 Added 2.94%
115,934 Common Stock
Dec 01 2023
SELL
Open market or private sale
$252,831 $58.58 p/Share
4,316 Reduced 3.7%
112,420 Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
$62,150 $14.4 p/Share
4,316 Added 3.57%
116,736 Common Stock
Jun 20 2023
BUY
Exercise of conversion of derivative security
$109,345 $11.33 p/Share
9,651 Added 7.91%
112,341 Common Stock
Jun 15 2023
SELL
Open market or private sale
$258,950 $51.79 p/Share
5,000 Reduced 4.91%
96,888 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
$294,142 $15.18 p/Share
19,377 Added 15.87%
102,690 Common Stock
Jun 13 2023
SELL
Open market or private sale
$241,200 $48.24 p/Share
5,000 Reduced 5.36%
88,313 Common Stock
Jun 13 2023
BUY
Exercise of conversion of derivative security
$72,000 $14.4 p/Share
5,000 Added 5.09%
93,313 Common Stock
May 18 2023
SELL
Open market or private sale
$442,000 $44.2 p/Share
10,000 Reduced 10.25%
87,598 Common Stock
RZ

Rong Zhou

SENIOR EVP, PRODUCTION CENTER
Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH